CN112244289A - 一种促进围手术期病人康复的营养配方粉的制备方法 - Google Patents
一种促进围手术期病人康复的营养配方粉的制备方法 Download PDFInfo
- Publication number
- CN112244289A CN112244289A CN202011139241.6A CN202011139241A CN112244289A CN 112244289 A CN112244289 A CN 112244289A CN 202011139241 A CN202011139241 A CN 202011139241A CN 112244289 A CN112244289 A CN 112244289A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- nutritional formula
- compound
- promoting
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 42
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 38
- 238000011084 recovery Methods 0.000 title claims abstract description 22
- 230000001737 promoting effect Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 150000001875 compounds Chemical class 0.000 claims abstract description 31
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 22
- 239000011707 mineral Substances 0.000 claims abstract description 22
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 12
- 244000068988 Glycine max Species 0.000 claims abstract description 12
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims abstract description 12
- 229930182816 L-glutamine Natural products 0.000 claims abstract description 12
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 12
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 12
- 239000004376 Sucralose Substances 0.000 claims abstract description 12
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 12
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 12
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 12
- 239000003921 oil Substances 0.000 claims abstract description 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 12
- 235000012239 silicon dioxide Nutrition 0.000 claims abstract description 12
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 12
- 235000019408 sucralose Nutrition 0.000 claims abstract description 12
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 12
- 235000019871 vegetable fat Nutrition 0.000 claims abstract description 12
- 229920001353 Dextrin Polymers 0.000 claims abstract description 11
- 239000004375 Dextrin Substances 0.000 claims abstract description 11
- 235000019425 dextrin Nutrition 0.000 claims abstract description 11
- 235000021119 whey protein Nutrition 0.000 claims abstract description 11
- 239000000126 substance Substances 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims description 21
- -1 compound vitamin Chemical class 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 6
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 3
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 229960000304 folic acid Drugs 0.000 claims description 3
- 235000019152 folic acid Nutrition 0.000 claims description 3
- 239000011724 folic acid Substances 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 239000011777 magnesium Substances 0.000 claims description 3
- 229910052749 magnesium Inorganic materials 0.000 claims description 3
- 235000001968 nicotinic acid Nutrition 0.000 claims description 3
- 229960003512 nicotinic acid Drugs 0.000 claims description 3
- 239000011664 nicotinic acid Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 229940055726 pantothenic acid Drugs 0.000 claims description 3
- 235000019161 pantothenic acid Nutrition 0.000 claims description 3
- 239000011713 pantothenic acid Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 235000019155 vitamin A Nutrition 0.000 claims description 3
- 239000011719 vitamin A Substances 0.000 claims description 3
- 239000011691 vitamin B1 Substances 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 239000011716 vitamin B2 Substances 0.000 claims description 3
- 239000011726 vitamin B6 Substances 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 229940045997 vitamin a Drugs 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 239000011701 zinc Substances 0.000 claims description 3
- 229910052725 zinc Inorganic materials 0.000 claims description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- 229930003451 Vitamin B1 Natural products 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- 229930003471 Vitamin B2 Natural products 0.000 claims 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims 1
- 229960002477 riboflavin Drugs 0.000 claims 1
- 229960003495 thiamine Drugs 0.000 claims 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 1
- 235000010374 vitamin B1 Nutrition 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- 235000019164 vitamin B2 Nutrition 0.000 claims 1
- 235000019158 vitamin B6 Nutrition 0.000 claims 1
- 229940011671 vitamin b6 Drugs 0.000 claims 1
- 230000035764 nutrition Effects 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 8
- 230000035876 healing Effects 0.000 abstract description 5
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000008569 process Effects 0.000 abstract description 4
- 208000015181 infectious disease Diseases 0.000 abstract description 3
- 230000002980 postoperative effect Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 2
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 230000000052 comparative effect Effects 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 3
- 231100000241 scar Toxicity 0.000 description 3
- 208000032544 Cicatrix Diseases 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000007873 sieving Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000000662 T-lymphocyte subset Anatomy 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000012856 weighed raw material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/60—Sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及营养保健食品技术领域,尤其涉及一种促进围手术期病人康复的营养配方粉及其制备方法。该营养配方粉包括浓缩乳清蛋白、粉末油脂、植物脂肪粉、麦芽糊精、大豆肽、复配矿物质、L‑谷氨酰胺、抗性糊精、二氧化硅、复配维生素、三氯蔗糖。该营养配方粉组方科学、营养,用于补充创伤、感染等应激状态下人群的全方位营养,提升整个手术治疗过程中的免疫力和术后愈合能力。
Description
技术领域
本发明涉及营养保健食品技术领域,尤其涉及促进围手术期病人康复的营养配方粉的制备方法。
背景技术
围手术期是围绕手术的一个全过程,从病人决定接受手术治疗开始,到手术治疗直至基本康复,包含手术前、手术中及手术后的一段时间,具体是指从确定手术治疗时起,直到与这次手术有关的治疗基本结束为止,时间约在术前5-7天至术后7-12天。
由于疾病及手术治疗均对患者身体的创伤及影响严重,容易造成患者正常生理代谢紊乱、营养不良、免疫力下降、伤口愈合周期长等问题,极易造成患者体质的虚弱和身体机能的下降。现有围手术期治疗过程中,患者一般会进行各类蛋白质、氨基酸、矿物质等营养素的补充,但由于手术的刺激、伤口组织的愈合需要时间恢复,患者在整个围手术期的不同阶段需要的营养搭配及补充量可能存在差异,因此,单纯无规律的依靠营养素的营养效用进行适当补充,忽略了患者机体的实际需求这一大环境,容易造成营养素补充的浪费或不足,不但不会提升患者身体机能,还容易造成患者恢复过程中的并发感染、延长患者机体恢复周期、影响患者术后身体素质。
发明内容
本发明提供了一种促进围手术期病人康复的营养配方粉的制备方法,组方科学、营养,用于补充创伤、感染等应激状态下人群的全方位营养,提升整个手术治疗过程中的免疫力和术后愈合能力,解决了现有技术中存在的问题。
本发明所采用的技术方案之一是:
一种促进围手术期病人康复的营养配方粉,包括以下原料:
浓缩乳清蛋白、粉末油脂、植物脂肪粉、麦芽糊精、大豆肽、复配矿物质、L-谷氨酰胺、抗性糊精、二氧化硅、复配维生素、三氯蔗糖。
进一步的,所述的促进围手术期病人康复的营养配方粉,各原料的重量百分含量为:
浓缩乳清蛋白28%-32%、粉末油脂8%-12%、植物脂肪粉3%-7%、麦芽糊精38%-42%、大豆肽8%-12%、复配矿物质1%-1.5%、L-谷氨酰胺1.5%-2.5%、抗性糊精0.8%-1.2%、二氧化硅0.1%-0.3%、复配维生素0.2%-0.6%、三氯蔗糖0.1%-0.3%。
进一步的,所述的促进围手术期病人康复的营养配方粉,各原料的重量百分含量为:
浓缩乳清蛋白30%、粉末油脂10%、植物脂肪粉5%、麦芽糊精40%、大豆肽10%、复配矿物质1.3%、L-谷氨酰胺1.9%、抗性糊精1%、二氧化硅0.2%、复配维生素0.4%、三氯蔗糖0.2%。
进一步的,所述复配维生素由以下活性成分的一种或多种制成:维生素A、维生素D、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、烟酸、叶酸、泛酸;所述复配矿物质由以下活性成分的一种或多种制成:镁、钙、铁、锌。
进一步的,所述营养配方粉为固体饮料制剂或片剂。
进一步的,上述复配维生素的各成分,按复配维生素总重量(g)计,由以下含量各活性成分组成:
维生素A 1250μg/g、维生素D 3.75μg/g、维生素E 22.5mg/g、维生素B1 2.8mg/g、维生素B2 2.8mg/g、维生素B6 2.8mg/g、维生素B12 4.5μg/g、维生素C 312.5mg/g、烟酸11.5mg/g、叶酸153.8μg/g、泛酸3.8mg/g。
进一步的,上述复配矿物质的各成分,按复配矿物质总重量(g)计,由以下含量各活性成分组成:
镁124.6mg/g、钙269.2mg/g、铁9.2mg/g、锌6.92mg/g。
本发明所采用的技术方案之二是:
一种促进围手术期病人康复的营养配方粉的制备方法,包括如下步骤:
(1)按配方取各原料,筛分、备用;
(2)混合:将步骤(1)的各原料投入至混合机,充分混合;
(3)内包装,即得固体饮料制剂。
本发明所采用的技术方案之三是:
一种促进围手术期病人康复的营养配方粉的制备方法,包括如下步骤:
(1)按配方称取各原料,备用;
(2)制粒:将各原料投入制粒机,混合,加入粘合剂75%酒精,低速搅拌时间,然后打开低速切刀;再开高速搅拌、高速切刀;放料;
(3)干燥:将步骤(2)制粒的颗粒投入沸腾干燥制粒机中,干燥至水分含量3-5%;
(4)混合:将步骤(3)的干燥处理颗粒和硬脂酸镁、乳粉投入至混合机,混合;即得压片糖果制剂。
进一步的,步骤(2)低速搅拌时间为2min;低速切刀2min;高速搅拌5min、高速切刀5min;步骤(3)干燥温度45-55℃,干燥时间28-35min。
本发明的有益效果:
本发明的促进围手术期病人康复的营养配方粉组分搭配科学、合理,针对围手术期病人的营养需求和愈后而设计,能够提供给患者在围手术期所需要的的营养,调节患者机体正常生理机能,提升免疫力,促进患者手术创伤及伤口的愈合周期。
具体实施方式
为能清楚说明本方案的技术特点,下面通过具体实施方式,对本发明进行详细阐述。
实施例1
该促进围手术期病人康复的营养配方粉,包括以下重量含量的原料:
浓缩乳清蛋白30g、粉末油脂10g、植物脂肪粉5g、麦芽糊精40g、大豆肽10g、复配矿物质1.3g、L-谷氨酰胺1.9g、抗性糊精1g、二氧化硅0.2g、复配维生素0.4g、三氯蔗糖0.2g;共计100g;
其中,复配矿物质和复配维生素的含量如下:
上述营养配方粉的制备方法包括如下操作步骤:
(1)原料验收:按照生产指令验收生产所需的上述各原料;
(2)粉碎、过筛:将需粉碎原料进行粉碎过筛;
(3)称量配料:按照配方用量进行称量各原料;
(4)混合:将称量好的各原料投入到混合机,封闭严密,防止漏料,混合30min;
(5)包装。
实施例2
该促进围手术期病人康复的营养配方粉,包括以下重量含量的原料:
浓缩乳清蛋白28g、粉末油脂12g、植物脂肪粉3g、麦芽糊精39g、大豆肽12g、复配矿物质1.5g、L-谷氨酰胺2.5g、抗性糊精1g、二氧化硅0.3g、复配维生素0.5g、三氯蔗糖0.2g,共计100g。
其中,复配矿物质和复配维生素的含量如下:
制备方法同实施例1的制备过程。
实施例3
该促进围手术期病人康复的营养配方粉,包括以下重量含量的原料:
浓缩乳清蛋32g、粉末油脂8g、植物脂肪粉5g、麦芽糊精40g、大豆肽11g、复配矿物质1.1g、L-谷氨酰胺1.5g、抗性糊精0.8g、二氧化硅0.1g、复配维生素0.2g、三氯蔗糖0.3g,总共100g;
其中,复配矿物质和复配维生素的含量如下:
制备方法同实施例1的制备过程。
用法用量:
加粉量(g) | 加水量(mL) | 次数(次/日) | |
营养补充 | 45 | 170 | 1-8 |
先加少量水,加水温度60℃左右,充分搅拌,再加入剩余水量;服用即可。
对比例1
一种用于围手术期病人康复的营养配方粉,相比实施例1,去除抗性糊精,总量不变,包括以下重量含量的原料:
浓缩乳清蛋白30g、粉末油脂10g、植物脂肪粉5g、麦芽糊精41g、大豆肽10g、复配矿物质1.3g、L-谷氨酰胺1.9g、二氧化硅0.2g、复配维生素0.4g、三氯蔗糖0.2g;共计100g;
其中,复配矿物质和复配维生素的含量如下:
对比例2
一种用于围手术期病人康复的营养配方粉,相比实施例1,改变复配矿物质和复配维生素各自含量,总量不变,包括以下重量含量的原料:
浓缩乳清蛋白30g、粉末油脂10g、植物脂肪粉5g、麦芽糊精41g、大豆肽10g、复配矿物质1g、L-谷氨酰胺1.9g、二氧化硅0.2g、复配维生素0.7g、三氯蔗糖0.2g;共计100g;
其中,复配矿物质和复配维生素的含量如下:
临床观察:
一、对象:受试患者100人,男女各半,年龄20-60岁;均为肢干位置的重伤伤口。
二、分组:对照组(对照组1、对照组2)、实施例组(实施例1-3)、对比例组(对比例1、对比例2),各组20人。
三、方法:各组分别按照正常治疗方式及手术治疗进行。对照组服用全淀粉类产品,用法用量按照本发明实施例的用法用量进行,实施例组按照上述用法用量使用,对比例组按照上述对比例的配方及实施例组的用法用量使用。
四、结果:
通过对各组患者的伤口愈合天数、疤痕情况、血清免疫球蛋白(Ig)、T细胞亚群分析,表明,本发明3组实施例组的患者伤口恢复情况远优于对照组和对比例组1和2,伤口愈合后的疤痕外在显现及褶皱情况,本发明3组实施例组的患者伤口愈合位置光滑,相比对照组的褶皱明显,对比例组的疤痕凸起,具有显著的区别;血清免疫球蛋白定量分析,本发明3组实施例组的患者在整个围手术期的免疫力整体明显高于对比例组和对照组患者。
上述具体实施方式不能作为对本发明保护范围的限制,对于本技术领域的技术人员来说,对本发明实施方式所做出的任何替代改进或变换均落在本发明的保护范围内。
本发明未详述之处,均为本技术领域技术人员的公知技术。
Claims (6)
1.一种促进围手术期病人康复的营养配方粉,其特征在于,包括以下原料:
浓缩乳清蛋白、粉末油脂、植物脂肪粉、麦芽糊精、大豆肽、复配矿物质、L-谷氨酰胺、抗性糊精、二氧化硅、复配维生素、三氯蔗糖。
2.根据权利要求1所述的促进围手术期病人康复的营养配方粉,其特征在于,各原料的重量百分含量为:
浓缩乳清蛋白28%-32%、粉末油脂8%-12%、植物脂肪粉3%-7%、麦芽糊精38%-42%、大豆肽8%-12%、复配矿物质1%-1.5%、L-谷氨酰胺1.5%-2.5%、抗性糊精0.8%-1.2%、二氧化硅0.1%-0.3%、复配维生素0.2%-0.6%、三氯蔗糖0.1%-0.3%。
3.根据权利要求2所述的促进围手术期病人康复的营养配方粉,其特征在于,各原料的重量百分含量为:
浓缩乳清蛋白30%、粉末油脂10%、植物脂肪粉5%、麦芽糊精40%、大豆肽10%、复配矿物质1.3%、L-谷氨酰胺1.9%、抗性糊精1%、二氧化硅0.2%、复配维生素0.4%、三氯蔗糖0.2%。
4.根据权利要求1-3任一所述的促进围手术期病人康复的营养配方粉,其特征在于,所述复配维生素由以下活性成分的一种或多种制成:维生素A、维生素D、维生素E、维生素B1、维生素B2、维生素B6、维生素B12、维生素C、烟酸、叶酸、泛酸;所述复配矿物质由以下活性成分的一种或多种制成:镁、钙、铁、锌。
5.根据权利要求1-3任一所述的促进围手术期病人康复的营养配方粉,其特征在于,所述营养配方粉为固体饮料制剂或片剂。
6.一种促进围手术期病人康复的营养配方粉的制备方法,其特征在于,包括如下步骤:
(1)按配方取各原料,筛分、称量备用;
(2)混合:将步骤(1)的各原料投入至混合机,充分混合;
(3)内包装,即得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011139241.6A CN112244289A (zh) | 2020-10-22 | 2020-10-22 | 一种促进围手术期病人康复的营养配方粉的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011139241.6A CN112244289A (zh) | 2020-10-22 | 2020-10-22 | 一种促进围手术期病人康复的营养配方粉的制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112244289A true CN112244289A (zh) | 2021-01-22 |
Family
ID=74264683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011139241.6A Pending CN112244289A (zh) | 2020-10-22 | 2020-10-22 | 一种促进围手术期病人康复的营养配方粉的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112244289A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113951411A (zh) * | 2021-08-31 | 2022-01-21 | 国药一心制药有限公司 | 一种复合乳清蛋白固体饮料配方及其制备工艺 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104957536A (zh) * | 2015-05-27 | 2015-10-07 | 广东省农业科学院蚕业与农产品加工研究所 | 一种预消化型全谷物营养膳及其制作方法 |
CN109198625A (zh) * | 2017-06-30 | 2019-01-15 | 况代武 | 一种短肽型营养食品配方 |
CN110663956A (zh) * | 2019-11-11 | 2020-01-10 | 宁波特壹食品有限公司 | 术后康复配方粉及其制备方法 |
-
2020
- 2020-10-22 CN CN202011139241.6A patent/CN112244289A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104957536A (zh) * | 2015-05-27 | 2015-10-07 | 广东省农业科学院蚕业与农产品加工研究所 | 一种预消化型全谷物营养膳及其制作方法 |
CN109198625A (zh) * | 2017-06-30 | 2019-01-15 | 况代武 | 一种短肽型营养食品配方 |
CN110663956A (zh) * | 2019-11-11 | 2020-01-10 | 宁波特壹食品有限公司 | 术后康复配方粉及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113951411A (zh) * | 2021-08-31 | 2022-01-21 | 国药一心制药有限公司 | 一种复合乳清蛋白固体饮料配方及其制备工艺 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101849669B (zh) | 一种复合营养美体剂 | |
CN102551073B (zh) | 一种含α-乳白蛋白和乳铁蛋白的营养组合物及其应用 | |
CN101696444B (zh) | 多肽提取物及其制备方法和应用 | |
KR101717893B1 (ko) | 고지혈증 개선제 및 빈혈 개선 조성물, 요산치 저하 조성물 및 음식품 | |
CN102018159B (zh) | 一种免疫增强型营养膳及其制作方法 | |
CN103223128B (zh) | 一种改善营养性贫血的中药组合物及其制备方法 | |
CN102731331A (zh) | 一种l-天门冬氨酸钙及其制备方法 | |
CN115997920A (zh) | 一种用于创伤患者的全营养医学用途配方食品 | |
CN103815227A (zh) | 一种复合维生素红糖组合物及其应用 | |
CN109247482A (zh) | 糖尿病患者固体饮料及其制备方法 | |
CN101279089B (zh) | 阿胶钙组合物及其制备方法 | |
CN112244289A (zh) | 一种促进围手术期病人康复的营养配方粉的制备方法 | |
RU2309751C1 (ru) | Способ лечения нарушений минерального обмена при артрите, или остеохондрозе, или рахите, или артрозе, или остеопорозе | |
CN105533699A (zh) | 一种儿童补锌与维生素组合物及其制备方法和应用 | |
CN103815226A (zh) | 一种蛋白红糖组合物及其应用 | |
CN111513200A (zh) | 一种益生菌饲料生产无公害猪肉的方法 | |
CN113729211A (zh) | 一种组合物及其制备方法、应用 | |
CN102579956A (zh) | 一种药物组合物及其应用 | |
CN111493221A (zh) | 一种提高动物免疫力的中药饲料添加剂及其制备方法 | |
CN104206824A (zh) | 草鱼混配饲料 | |
CN109363155A (zh) | 一种野生菌功能型保健品制备方法及其制品 | |
JP2001019642A (ja) | 粉末状天然真珠を主成分とする滋養強壮剤の製法とその利用方法 | |
CN210695804U (zh) | 医用食品制备装置 | |
CN109953332A (zh) | 一种玫瑰钙片及其制备方法 | |
CN1303904C (zh) | 橄榄钙片 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210122 |
|
RJ01 | Rejection of invention patent application after publication |